0.78
Cue Biopharma Inc Azioni (CUE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
601.66%
2.954
|
0.421 | 1.576 | 3.336 | 2.658 |
|
8.89%
11.59
|
12.72 | 11.21 | 12.15 | 13.04 |
Benefits Costs and Expenses |
100.00%
-
|
12.68 | 11.07 | - | - |
Costs And Expenses |
8.59%
11.59
|
12.68 | 11.07 | 12.15 | 13.04 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
1.98%
0.099
|
0.101 | 0.098 | 0.101 | 0.099 |
Operating Income/Loss |
29.79%
-8.635
|
-12.30 | -9.633 | -8.815 | -10.38 |
Net Interest Income/Expense |
64.84%
-0.045
|
-0.128 | -0.153 | -0.188 | -0.215 |
Nonoperating Income/Loss |
264.29%
0.153
|
0.042 | 0.137 | 0.155 | 0.212 |
Income/Loss From Continuing Operations Before Tax |
124.10%
2.954
|
-12.26 | -9.496 | 3.336 | 2.658 |
Income/Loss From Continuing Operations After Tax |
30.80%
-8.482
|
-12.26 | -9.496 | -8.66 | -10.17 |
|
30.80%
-8.482
|
-12.26 | -9.496 | -8.66 | -10.17 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
28.56%
95.46
|
74.25 | 6.0354 | 51.23 | 50.17 |
Diluted Average Shares |
28.56%
95.46
|
74.25 | 6.0354 | 51.23 | 50.17 |
Basic Earnings Per Share |
47.06%
-0.09
|
-0.17 | -0.10 | -0.17 | -0.20 |
Diluted Earnings Per Share |
47.06%
-0.09
|
-0.17 | -0.10 | -0.17 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):